|
Market Closed -
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 0.3915 USD | +5.55% |
|
-48.04% | -60.85% |
| 09-02 | Needham Downgrades TScan Therapeutics to Hold From Buy | MT |
| 09-02 | Wedbush Downgrades TScan Therapeutics to Neutral From Outperform, Adjusts Price Target to $1 From $5 | MT |
| Market Cap | 26.54M 22.82M 21.46M 19.59M 36.64M 2.51B 36.76M 254M 98.37M 1.29B 99.65M 97.47M 4.09B | P/E 2026 * |
-0.45x | P/E 2027 * | -0.52x |
|---|---|---|---|---|---|
| Enterprise Value | -72.33M -62.21M -58.51M -53.41M -99.88M -6.84B -100M -694M -268M -3.5B -272M -266M -11.16B | EV / Sales 2026 * |
-13.1x | EV / Sales 2027 * | -10.2x |
| Free-Float |
93.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TCRX | Delayed | |
CBOE
| TCRX | Real-time |
Last Transcript : TScan Therapeutics, Inc.
| 1 day | +5.55% | ||
| 1 week | -48.04% | ||
| Current month | -46.35% | ||
| 1 month | -48.70% | ||
| 3 months | -60.13% | ||
| 6 months | -65.04% | ||
| Current year | -60.85% |
| 1 week | 0.35 |  | 0.77 |
| 1 month | 0.35 | | 0.84 |
| Current year | 0.35 | | 1.47 |
| 1 year | 0.35 | | 2.57 |
| 3 years | 0.35 | | 9.69 |
| 5 years | 0.35 | | 9.69 |
| 10 years | 0.35 | | 14.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin MacBeath
CEO | Chief Executive Officer | 56 | 2023-03-27 |
Dawn Pinchasik
CTO | Chief Tech/Sci/R&D Officer | - | 2024-02-05 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Katina Dorton
BRD | Director/Board Member | 68 | 2021-03-22 |
Gavin MacBeath
BRD | Director/Board Member | 56 | 2023-05-23 |
Stephen Biggar
CHM | Chairman | 55 | 2024-06-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/20/26 | Free | Director | 67,000 | 0.1200% | ||
| 5/20/26 | Free | Director | 67,000 | 0.1200% | ||
| 5/20/26 | Free | Director | 67,000 | 0.1200% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.55% | -48.04% | -79.50% | -84.71% | 26.54M | |
| -0.38% | -2.64% | +42.69% | +99.03% | 67.98B | |
| -2.71% | -2.88% | +35.89% | +80.22% | 64.94B | |
| -0.31% | +6.54% | -12.96% | +377.83% | 27.58B | |
| +0.86% | +1.65% | -7.74% | -13.58% | 26.06B | |
| -1.42% | -4.28% | +31.24% | +13.27% | 25.74B | |
| -1.11% | -0.70% | +22.24% | -17.69% | 20.09B | |
| +1.15% | -14.24% | +219.82% | +381.14% | 17.16B | |
| +0.20% | -4.68% | -6.41% | +560.92% | 14.92B | |
| -0.20% | +8.37% | +55.78% | +165.57% | 14.62B | |
| Average | +0.16% | -3.86% | +30.10% | +156.20% | 27.91B | |
| Weighted average by Cap. | -0.81% | +0.58% | +37.31% | +140.87% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.51M 4.73M 4.45M 4.06M 7.6M 521M 7.63M 52.8M 20.41M 267M 20.67M 20.22M 849M | 4.71M 4.05M 3.81M 3.48M 6.51M 446M 6.53M 45.19M 17.47M 228M 17.69M 17.31M 727M |
| Net income | -114M -98.16M -92.33M -84.28M -158M -10.8B -158M -1.09B -423M -5.53B -429M -419M -17.61B | -101M -86.7M -81.55M -74.44M -139M -9.53B -140M -967M -374M -4.88B -379M -370M -15.55B |
| Net Debt | -98.87M -85.03M -79.97M -73M -137M -9.35B -137M -948M -367M -4.79B -371M -363M -15.25B | -74.76M -64.29M -60.47M -55.2M -103M -7.07B -104M -717M -277M -3.62B -281M -275M -11.53B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | US$0.3915 | +5.55% | 1,674,586 |
| 26-09-03 | US$0.3709 | -2.68% | 3,092,974 |
| 26-09-02 | US$0.3811 | -42.80% | 8,517,352 |
| 26-09-01 | US$0.6663 | -8.69% | 820,279 |
| 26-08-31 | US$0.7297 | -3.16% | 330,387 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TCRX Stock
Select your edition
All financial news and data tailored to specific country editions
